AE Wealth Management »

Lineage Cell Therapeutics In shares owned by AE Wealth Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by AE Wealth Management from 13F filings

Historical chart of AE Wealth Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by AE Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by AE Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17k 16k 1.10
2023-09-30 $18k 16k 1.18

More positions owned by AE Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Ishares Tr Rus Tp200 Gr Etf (IWY)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Aim Etf Products Trust Us Lrgcp B20 Jan (JANW)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus Tp200 Vl Etf (IWX)

View all positions for AE Wealth Management

Top funds holding Lineage Cell Therapeutics In

BlackRock
Vanguard Group
Defender Capital
Geode Capital Management
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
Citadel Advisors
Nuveen Asset Management
Laurion Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Long Focus Capital Management
Connor, Clark & Lunn Investment Management

View all funds holding Lineage Cell Therapeutics In